Dr. Tishya Indran, Haematology, Best Researcher Award

Doctorate at Walter and Eliza Hall Institute, Australia

Professional Profile

Scopus Profile


Dr. Tishya Indran is a highly skilled haematologist and researcher based in Melbourne, Victoria, Australia. She holds dual fellowships in Clinical Haematology from the Royal Australian College of Physicians (FRACP) and the Royal College of Pathologists Australasia (FRCPA). Dr. Indran is currently a Clinical and Laboratory Haematology Diagnostic Fellow at RMH and a third-year PhD student at the Walter and Eliza Hall Institute.


Dr. Tishya Indran completed her Bachelor of Medicine, Bachelor of Surgery (MBBS) at The University of Adelaide in 2005. She subsequently pursued advanced training in haematology, achieving fellowships from both the Royal Australian College of Physicians (FRACP) and the Royal College of Pathologists Australasia (FRCPA) in 2018. This rigorous academic foundation has equipped her with comprehensive expertise in clinical haematology, laboratory diagnostics, and cutting-edge research methodologies.

๐Ÿ’ผ Professional Experience

  • 2022 – Present: Clinical and Laboratory Haematology Diagnostic Fellow, RMH
  • 2021 – 2022: Consultant Haematologist, Latrobe Regional Hospital
  • 2019 – 2022: Clinical Haematology Fellow, The Alfred Hospital
  • Various roles including research and clinical fellowships in haemostasis, thrombosis, and laboratory haematology across prestigious institutions in Australia and the USA.

๐Ÿ”ฌ Research Interests

Dr. Tishya Indran is deeply committed to advancing knowledge in haematology, with a primary focus on haematological malignancies, stem cell transplantation, and thrombotic disorders. Her research explores innovative therapies and diagnostic approaches aimed at improving patient outcomes in these complex and challenging areas of clinical practice. Dr. Indran’s work is characterized by a blend of clinical insight and scientific inquiry, contributing to advancements in understanding disease mechanisms and developing targeted treatment strategies.

๐Ÿ“– Publication Top Noted

Safety of rapid injection of undiluted ferric carboxymaltose to patients with iron-deficiency anaemia: a Phase II single-arm study

    • Authors: Pasricha, S.-R., Gilbertson, M., Indran, T., Chunilal, S., Opat, S.
    • Journal: Internal Medicine Journal
    • Volume: 51
    • Issue: 8
    • Pages: 1304โ€“1311
    • Year: 2021

The COVID-19 Pandemic and the Need for an Integrated and Equitable Approach: An International Expert Consensus Paper

    • Authors: Gerotziafas, G.T., Catalano, M., Theodorou, Y., Siess, W., Weber, C.
    • Journal: Thrombosis and Haemostasis
    • Volume: 121
    • Issue: 8
    • Pages: 992โ€“1007
    • Year: 2021

Red cell transfusion in outpatients with myelodysplastic syndromes: a feasibility and exploratory randomised trial

    • Authors: Stanworth, S.J., Killick, S., McQuilten, Z.K., Jones, A., Player, M.
    • Journal: British Journal of Haematology
    • Volume: 189
    • Issue: 2
    • Pages: 279โ€“290
    • Year: 2020

Utility of a Nurse-Led Pathway for Patients with Acute Venous Thromboembolism Discharged on Rivaroxaban: A Prospective Cohort Study

    • Authors: Lim, M.S., Indran, T., Cummins, A., Chan, N.C., Chunilal, S.
    • Journal: Seminars in Thrombosis and Hemostasis
    • Volume: 45
    • Issue: 2
    • Pages: 187โ€“195
    • Year: 2019

Donor Lymphocyte Infusion (DLI) post allogeneic stem cell transplant (allo-SCT) in Acute Myeloid Leukemia (AML) and High-Grade Myelodysplastic Syndrome (MDS). A longitudinal retrospective study using peripheral blood (PB) CD34+ and CD3+ donor chimerism (DC) monitoring

  • Authors: Indran, T., Das, T., Muirhead, J., Patil, S., Curtis, D.J.
  • Journal: Leukemia Research
  • Volume: 142
  • Pages: 107504
  • Year: 2024
Tishya Indran| Haematology | Best Researcher Award

You May Also Like